
Opinion|Videos|July 18, 2024
Emerging Breast Cancer Therapies and Closing Thoughts
A leading oncologist explores promising new breast cancer therapies in the drug development pipeline and advises healthcare providers on strategies to remain informed about the most current treatment guidelines and recommendations.
Advertisement
Episodes in this series

- What drug developments are targeting unmet needs in breast cancer treatment? What drugs are currently in the pipeline that you are excited about?
- How can healthcare providers stay updated with the latest breast cancer treatment guidelines?
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
Prescription Access Crisis: 40% of GLP-1 RA Rx Are Unfilled
2
FDA Expands Upadacitinib Label for Treating Inflammatory Bowel Disease
3
Value-Based Care Offers Solutions to Patient Access Challenges: Brian Mulherin, MD
4
New WHO Reports Sounds Alarm on Antimicrobial Resistance
5